Профиль компании
- Фондовый код
- CAPR
- ISIN-код
- US14070B3096
- Валюта
- US Dollar (USD)
- Дата IPO
- 2007-02-13

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States. Its lead product candidate is the Deramiocel, an allogeneic cardiosphere-derived cells, which is...